ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    CanStem111P
Previous Study | Return to List | Next Study

A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma (CanStem111P)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02993731
Recruitment Status : Recruiting
First Posted : December 15, 2016
Last Update Posted : October 16, 2018
Sponsor:
Information provided by (Responsible Party):
Boston Biomedical, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Study Completion Date : No date given